| __timestamp | Ionis Pharmaceuticals, Inc. | Ultragenyx Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 241751000 | 45967000 |
| Thursday, January 1, 2015 | 322292000 | 114737000 |
| Friday, January 1, 2016 | 344320000 | 183204000 |
| Sunday, January 1, 2017 | 374644000 | 231644000 |
| Monday, January 1, 2018 | 414604000 | 293998000 |
| Tuesday, January 1, 2019 | 466000000 | 357355000 |
| Wednesday, January 1, 2020 | 535000000 | 412084000 |
| Friday, January 1, 2021 | 643000000 | 497153000 |
| Saturday, January 1, 2022 | 833000000 | 705789000 |
| Sunday, January 1, 2023 | 899625000 | 648449000 |
Data in motion
In the competitive landscape of biotechnology, Ionis Pharmaceuticals, Inc. and Ultragenyx Pharmaceutical Inc. have been at the forefront of innovation. Over the past decade, both companies have significantly increased their investment in research and development (R&D), a critical driver of innovation.
Since 2014, Ionis Pharmaceuticals has consistently ramped up its R&D spending, with a remarkable 272% increase by 2023. This commitment underscores their dedication to pioneering new therapies and maintaining a competitive edge in the biotech sector.
Ultragenyx, while starting with a lower R&D budget, has shown an impressive growth trajectory, increasing its R&D expenses by over 1,300% from 2014 to 2023. This surge reflects their aggressive strategy to innovate and expand their therapeutic offerings.
Both companies exemplify the biotech industry's relentless pursuit of innovation, with Ionis leading in absolute spending and Ultragenyx showcasing rapid growth.
Comparing Innovation Spending: Eli Lilly and Company and Ionis Pharmaceuticals, Inc.
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Ionis Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for argenx SE and Ultragenyx Pharmaceutical Inc.
Research and Development Investment: Bio-Techne Corporation vs Ionis Pharmaceuticals, Inc.
R&D Insights: How Jazz Pharmaceuticals plc and Ultragenyx Pharmaceutical Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Halozyme Therapeutics, Inc. and Ultragenyx Pharmaceutical Inc.
R&D Spending Showdown: Blueprint Medicines Corporation vs Ultragenyx Pharmaceutical Inc.
Research and Development Investment: Ionis Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated
Amneal Pharmaceuticals, Inc. or Ultragenyx Pharmaceutical Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Ultragenyx Pharmaceutical Inc. and Vericel Corporation
Research and Development Expenses Breakdown: Ultragenyx Pharmaceutical Inc. vs Ligand Pharmaceuticals Incorporated
R&D Spending Showdown: Ultragenyx Pharmaceutical Inc. vs Xencor, Inc.